Immune Design Corporation To Present At Upcoming Investor Conferences In February
2/3/2014 8:57:38 AM
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Immune Design, a clinical-stage biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced that Carlos Paya, M.D., Ph.D., Chief Executive Officer, will present at two upcoming investor conferences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by